• Home
  • Leadership
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Therapeutic Programs
  • Media
  • Contact
GeneVentiv Therapeutics Receives Funding from the North Carolina Biotechnology Center

GeneVentiv Therapeutics Receives Funding from the North Carolina Biotechnology Center

by Damon Race | Jun 7, 2022 | Press

June 7, 2022 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood diseases and disorders, today announced the award of a $250,000 Strategic Research Loan (SRL) from the North Carolina...

Recent Posts

  • GeneVentiv Invited to Present at The National Hemophilia Foundation’s 17th Workshop
  • GeneVentiv Expands Management Team and Board of Directors
  • UNC-Chapel Hill gene therapy spinout raises $1.4 million
  • Bootstrapped UNC spinout lands $300K for gene therapy work
  • Triangle gene therapy startup GeneVentiv Therapeutics awarded $250K loan from NC Biotech Center

Recent Comments

    Archives

    • February 2023
    • January 2023
    • September 2022
    • June 2022
    • March 2022
    • February 2022
    • November 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020

    Categories

    • In the News
    • Press

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    • Please prove you are human by selecting the Tree.
    • This field is for validation purposes and should be left unchanged.

    Copyright © 2020 GeneVentiv Therapeutics. All rights reserved.